Project Grant R01EY036414
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$422K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Boston, MA 02111, USA
Similar Awards
This Project Grant award of $400,000.00 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to investigate the ontology and function of retinal perivascular macrophages during neuroinflammation. The research aims to determine the origin and longevity of these macrophages, as well as their role in experimental autoimmune uveitis and diabetic retinopathy. This work will advance the understanding of the blood-retina barrier and its disruption in...
This $670,496 Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to investigate the paradoxical role of anti-VEGF therapy in subretinal fibrosis (SRF) associated with neovascular age-related macular degeneration (NAMD). The project aims to elucidate the mechanisms by which anti-VEGF therapy at different disease stages impacts SRF, and to develop novel dual anti-angiogenesis and anti-fibrosis therapies. The...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) totaling $3,120,397 provides funding to The Medical University of South Carolina from Sep 1, 2024 to Apr 30, 2028 to develop and characterize a 3D tissue chip model of the retinal pigment epithelium (RPE)-choroid complex. The goal is to assess the influence of genetic risk factors and environmental stressors on complement activation and early pathological changes in age-related macular degeneration (AMD)....
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) in the amount of $247,700 will support the establishment of a chimeric mouse model to study human retinal microglia in vivo. The primary objectives are to: Characterize the engraftment and integration of human-induced pluripotent stem cell-derived microglia (xMGs) into the mouse retina and optic nerve, and assess the impact on host retinal cells and tissue organization. Use single-cell RNA sequencing to define...
This $606,034 Project Grant awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) supports research to investigate the role of Müller glia cells in the acute and chronic inflammatory response in the retina under various stress, injury, and disease conditions. The research aims to provide a deeper understanding of the molecular and cellular mechanisms that maintain retinal homeostasis and how those mechanisms are disrupted during acute and...
The National Eye Institute (NEI) awarded a $131,281 Project Grant under the Vision Research program (CFDA 93.867) to Northwestern University to support research on the role of myeloid cell transendothelial migration in non-proliferative diabetic retinopathy. The research aims to determine whether and when blocking CCL2-driven myeloid cell infiltration can halt the progression of inflammation in the mouse retina, and whether blocking leukocyte-endothelial interactions early in the disease...
This Project Grant award for $684,891.00 was provided by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867). The award to the Massachusetts Eye and Ear Infirmary, a non-profit hospital and research center affiliated with Harvard Medical School, will fund research to address the challenge of interpreting rare genetic variants of unknown significance in inherited retinal degenerations. The project aims to develop a high-throughput splicing assay to...
This $439,137 Project Grant was awarded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to the University of Arkansas for Medical Sciences (UAMS) to support research aimed at identifying cellular mechanisms and therapeutic targets for retinal neurovascular diseases such as diabetic retinopathy, retinal artery/vein occlusion, and traumatic optic neuropathy. The research will focus on studying the process of "efferocytosis", which refers to the...
The U.S. National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to determine the role of G-coupled protein receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The project aims to investigate the affinities and substrate specificities of GPR31 and GPR39 for 12- and 15-HETE metabolites in retinal endothelial cells and Müller cells under normal and hyperglycemic conditions. It will also examine the effects of GPR31 or...
This federal Project Grant award, funded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), aims to determine how changes in the extracellular matrix (ECM) stiffness impact the epithelial-to-mesenchymal transition (EMT) of retinal pigmented epithelial (RPE) and choroidal endothelial cells (ChECs) associated with age-related macular degeneration (AMD). The $1,173,062 award, spanning from September 1, 2024 to March 31, 2029, will utilize in vitro and ex vivo...